Hovnanian valuation remains attractive, says UBS UBS said Hovnanian's valuation remains attractive following the Q2 report. The analyst remains optimistic on future earnings power and top-line growth. Shares are Buy rated with a $6 price target.
News For HOV From The Last 14 Days
Check below for free stories on HOV the last two weeks.